Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab versus watch and wait in advanced asymptomatic non-bulky follicular lymphoma
2004-001621-16Phase 3Completed
- Sponsor
- University College London
- Start
- Jun 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of rituximab in follicular lymphoma (FL) (2 arms), sponsored by University College London. Primary endpoint: Time until initiation of therapy. Started Jun 2007; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on 2004-001621-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001621-16.